Turn crop yields, farming trends, and resource data into focused market strategies.
Fortune Business Insights™ provides in-depth reports on every possible market falling under the animal nutrition (feed) sub-domain. the company is determined to aid organizations in developing their businesses in the industry by conducting thorough research to understand the market scenario. Animal nutrition is the science of feeding and feed preparation. In short, it deals with how feeds for animals are prepared and given to them to produce safe and adequate food and non-food materials, such as manure and wool. The availability of desired quantity and type of feed is the bedrock of the livestock production system. Animal nutrition is a multi-faceted theme. It shapes almost every livestock sub-sector present across the production systems. It can also have far reaching effects on global economy, food prices, poverty, and human nutrition. At the same time, it impacts sectors, such as animal welfare, health, and reproduction, as well as the environment, animal product quality and safety, and farm economic viability. The emergence of ‘omics’ and ‘molecular biology’ has opened door to various opportunities in understanding the fundamental nutrition in an efficient way. Companies operating in this industry are conducting applied and strategic research to get deep insights into the dynamics and interactions amongst how feed is prepared for building a sustainable society.
The aquafeed additives market size is projected to grow from $2.47 billion in 2026 to $3.59 billion by 2034, at a CAGR of 4.80% during the forecast period... Read More
The global pet food ingredients market size is projected to grow from $63.34 billion in 2026 to $106.61 billion by 2034, at a CAGR of 6.72% during 2026-2034... Read More
The global dog food market size is projected to grow from $80.34 billion in 2026 to $117.22 billion by 2034, at a CAGR of 4.84% during the forecast period... Read More
Japan pet food market size was USD 5.12 billion in 2025 and is projected to reach USD 8.90 billion by 2034, growing at a CAGR of 6.4% during 2026-2034.... Read More
The global wet pet food market size is projected to grow from $25.54 billion in 2026 to $35.67 billion by 2034, at a CAGR of 4.27% during the forecast period... Read More
The global pet food extrusion market size is projected to grow from $85.76 billion in 2026 to $133.63 billion by 2034, exhibiting a CAGR of 5.70%... Read More
The global cat food market size is projected to grow from $47.64 billion in 2026 to $74.95 billion by 2034, exhibiting a CAGR of 5.83% during the forecast period... Read More
The global feed acidifiers market size is projected to grow from $3,299.88 million in 2026 to $4,925.29 million by 2034, exhibiting a CAGR of 5.13%... Read More
The global feed acidulants market size was valued at USD 3.92 billion in 2025 and is projected to grow from USD 4.09 billion in 2026 to USD 6.36 billion by 2034, exh...... Read More
The global feed enzymes market size is projected to grow from $1.56 billion in 2026 to $2.38 billion by 2034, at a CAGR of 5.45% during the forecast period... Read More
The global feed antioxidants market size was valued at USD 371.38 billion in 2025. The market is projected to grow from USD 387.88 billion in 2026 to USD 598.92 bill...... Read More
The global pet food market size is projected to grow from $134.46 billion in 2026 to $199.50 billion by 2034, exhibiting a CAGR of 5.05% in the forecast period... Read More
The global pet supplements market size is projected to grow from $3.33 billion in 2026 to $5.47 billion by 2034, at a CAGR of 6.34% during the forecast period... Read More
The microalgae-based aquafeed market size is projected to grow from $296.84 million in 2026 to $583.88 million by 2034, exhibiting a CAGR of 7.84%... Read More
The global alfalfa market is projected to grow from $31.24 billion in 2026 to $53.46 billion by 2034 at a CAGR of 6.94% over the forecast period... Read More
The global compound feed market size was $611.25 billion in 2025 & is projected to grow from $641.51 billion in 2026 to $990.46 billion in 2034... Read More
The global aquafeed market size stood at $71.28 billion in 2025 & is likely to grow from $75.42 billion in 2026 to $131.07 billion by 2034 at a CAGR of 7.15%... Read More
The global citrus pulp pellets market size is valued at USD 883.48 million in 2026, projected to reach USD 1318.28 million by 2034 at a CAGR of 5.13% during 2026â203...... Read More
The global beet pulp pellets market size is valued at USD 204.21 million in 2026, projected to reach USD 345.92 million by 2034 at a CAGR of 6.81% during 2026â2034.... Read More
The global swine feed market size is projected to reach USD 171.55 billion by 2032, exhibiting a CAGR of 3.02%.... Read More
The primary objective of these reports is to provide data-driven insights about the healthcare burden, healthcare resources, healthcare infrastructure, healthcare services and installed base of key medical equipment. These reports can play a crucial role in the assessment of market potential based on healthcare needs and penetration of medical devices and drive the strategies to increase the demand for healthcare products.
Global healthcare spending reached USD 11.1 trillion in 2024 due to the evolving healthcare needs driven by the aging population and growth in burden of chronic diseases.
In 2024, healthcare expenditure accounted for roughly 10.0% of the global GDP. Although the per capita healthcare spending was around USD 1,354 globally, there is a huge disparity among developed and developing nations.
| Per Capita Healthcare Spending | |
|---|---|
| U.S. | USD 12,740 |
| Japan | USD 3,890 |
| China | USD 675 |
| Indonesia | USD 395 |
| India | USD 102 |
| Number of doctors per 1,000 people | |
|---|---|
| High-income countries | 3.7 |
| Middle-income countries | 2.3 |
| Low-income countries | 0.4 |
In terms of the healthcare infrastructure such as hospitals and hospitals beds, the disparity between developed, developing and under-developed countries is significant, similar to the data on healthcare spending and healthcare resources.
| Number of ICU beds per 100,000 people | |
|---|---|
| High-income countries | 12.8 |
| Middle-income countries | 5.6 |
| Low-income countries | Less than 2.5 |
This scope can be covered for the following set of countries:
The primary objective of epidemiology reports is to provide data-driven insights into the incidence, prevalence, and distribution of diseases across different populations, geographies and time periods. These reports can play a crucial role in the assessment of market potential based on patient populations and drive the strategies for the development for healthcare products such as pharmaceuticals, medical devices, or diagnostics. Epidemiology reports include segmentation by age, gender, region, and disease stage, enabling companies to make informed decisions about market entry, product positioning, and clinical trial planning.
Assist in the estimation of the potential/addressable market based on patient population
Provide an understanding of the trend in patient population
Provide an overview of the cost of care & therapeutics market
Provide an understanding of the disease landscape
Provide an understanding of the treated patient population
We can check the feasibility of adding specific countries to the geographic scope based on your requirements.
USA
UK
Germany
France
Italy
Spain
Japan
China
India
AustraliaGlobally, chronic diseases account for almost three-quarters of all deaths. At present, more than one in three adults have at least one chronic condition. Unhealthy lifestyle and ageing population are some of the main factors contributing to the growing burden of non-communicable diseases such as diabetes and cardiovascular conditions.
Management of chronic diseases and treatment of conditions due to these chronic diseases accounts for a significantly large proportion of the total healthcare spending of all countries, developed as well as
In the U.S., around 90% of the annual healthcare spending is on people suffering from chronic and mental conditions.
The World Economic Forum estimates that the global cost of treating chronic diseases will be around USD 30 trillion by 2030.
| DISEASE INDICATION |
U.S | U.K | Germany | France | Italy | Spain | Saudi Arabia | United Arab Emirates |
|---|---|---|---|---|---|---|---|---|
| Diabetes | 32.5 | 4.0 | 6.2 | 4.0 | 4.5 | 5.2 | 4.4 | 1.0 |
| Hypertension | 148.2 | 23.2 | 30.7 | 22.2 | 25.3 | 15.7 | 15.2 | 5.3 |
| Kidney Stone | 0.67 | 0.30 | 0.38 | 0.29 | 0.26 | 0.27 | 0.13 | 0.03 |
| Obesity | 109.3 | 23.6 | 21.3 | 13.6 | 10.4 | 10.3 | 10.1 | 3.9 |
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. If it is not treated, cancer can invade surrounding tissues and spread to other parts of the body.
Around 20 million new cancer cases are diagnosed every year with men accounting for roughly 51% of them. China, India, USA and Japan account for around 4% of new cancer cases globally.
| Type | Cancer Incidence |
|---|---|
| Trachea, Bronchus & Lung | 2.5 |
| Breast | 2.3 |
| Colorectum | 1.9 |
| Prostate | 1.5 |
| Stomach | 0.97 |
| Liver | 0.87 |
| Thyroid | 0.82 |
| Cervix Uteri | 0.66 |
| Bladder | 0.61 |
| Non-Hodgkin Lymphoma | 0.55 |
Lung Cancer, Breast Cancer, Colorectal Cancer and Prostate Cancer account for around 44% of the new cancer cases (excluding non-melanoma skin cancer).
Diabetes is a chronic medical condition in which the body either doesn't produce enough insulin or can't effectively use the insulin it produces, leading to elevated levels of glucose in the blood. Over time, high blood sugar can cause serious damage to the heart, kidneys, eyes, and nerves.
Around 540 million people suffer from diabetes globally with more than 40% of the cases undiagnosed.
The two main types of diabetes are Type 1 and Type2. Type 1 is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy whereas Type 2 is a metabolic disorder where the body either doesn't produce enough insulin or cells become resistant to its effects. Type 2 accounts for around 96% of the prevalent diabetes cases.
Type 1
12,504,087 (4.4%)Type 2
269,376,970 (95.6%)0â19 yrs
579,27620â44 yrs
46,553,35345â64 yrs
91,116,784>64 yrs
143,631,644Men
146,030,908 (51.8%)Women
135,850,149 (48.2%)Conditions that impair the function of the kidneys, which are responsible for filtering waste and excess fluids from the blood, are known as kidney diseases. These diseases can range from acute kidney injury to chronic kidney disease (CKD), which may progress to kidney failure if not managed properly. Common causes include diabetes, high blood pressure, infections, and genetic disorders.
Globally, around 700 million people are estimated to be suffering from chronic kidney disease (CKD). Around 14% of adults in the U.S. are estimated to have CKD. Kidney diseases account for almost 2-4% of the total healthcare budgets in many developed nations. In the U.S., the annual cost of kidney diseases is estimated to be more than USD 85 billion.
Around 2 million people worldwide suffer from end-stage renal disease (ESRD), for which they receive dialysis or kidney transplants.
|
USA
|
750,000 |
|
Japan
|
350,000 |
|
Brazil
|
200,000 |
|
Germany
|
80,000 |
|
UK
|
70,000 |
A condition affecting less than 65 per 100,000 people is defined as a rare disease by the WHO. The global prevalence of more than 7,000 rare diseases together is around 300 million. More than 65% of the patients suffering from rare diseases are children and majority of these diseases do not have any treatment.
| Cystic Fibrosis | Lou Gehrig's Disease (ALS) | Huntington's Disease | Duchenne Muscular Dystrophy (DMD) |
|---|---|---|---|
| 40,000 | 18,000 | 30,000 | 15,000 |
Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. They are the leading cause of death globally, often resulting from a combination of lifestyle factors and underlying health conditions.
It is estimated that around 60% of the U.S. adults will have some form of cardiovascular disease (CVD) in the next 30 years and the cost (direct and indirect) of CVD will be around USD 1.8 trillion. Globally, around 700 million people are living with CVDs and CVDs account for around one in three deaths every year.
Download Sample